ACTM-838: A Novel Microbial Modality That Safely Enriches in TME After IV Dosing & Comprehensively Reactivates the Immunosuppressive TME for a Durable Anti-Tumor Immunity
Time: 3:15 pm
day: Conference Day 1
Details:
To view full session details, download the agenda here
